儿科指南

订阅

MedSci主页 / 所有栏目 / 儿科指南

NICE指南：婴儿、儿童和青少年的医疗保健经验[NG204]

2021-08-25 英国国家卫生与临床优化研究所 NICE

医疗保健

该指南描述了婴儿、儿童和年轻人的良好患者体验，并就如何交付提供了建议。它旨在确保所有使用 NHS 服务的婴儿、儿童和青少年都能获得最佳的护理体验。父母和看护人的作用得到认可，我们在制定建议时酌情考虑了

中文标题：

NICE指南：婴儿、儿童和青少年的医疗保健经验[NG204]

英文标题：

Babies, children and young people's experience of healthcare

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-08-25

简要介绍：

该指南描述了婴儿、儿童和年轻人的良好患者体验，并就如何交付提供了建议。它旨在确保所有使用 NHS 服务的婴儿、儿童和青少年都能获得最佳的护理体验。父母和看护人的作用得到认可，我们在制定建议时酌情考虑了他们的意见。

相关资料下载：
[AttachmentFileName(sort=1, fileName=婴儿、儿童和青少年的医疗保健经验.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f6ebb1c002166353, title=NICE指南：婴儿、儿童和青少年的医疗保健经验[NG204], enTitle=Babies, children and young people's experience of healthcare, guiderFrom=NICE, authorId=0, author=, summary=该指南描述了婴儿、儿童和年轻人的良好患者体验，并就如何交付提供了建议。它旨在确保所有使用 NHS 服务的婴儿、儿童和青少年都能获得最佳的护理体验。父母和看护人的作用得到认可，我们在制定建议时酌情考虑了, cover=https://img.medsci.cn/2021829/1630246338718_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Aug 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>该指南描述了婴儿、儿童和年轻人的良好患者体验，并就如何交付提供了建议。它旨在确保所有使用 NHS 服务的婴儿、儿童和青少年都能获得最佳的护理体验。父母和看护人的作用得到认可，我们在制定建议时酌情考虑了他们的意见。</p>, tagList=[TagDto(tagId=11077, tagName=医疗保健)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11077, guiderKeyword=医疗保健, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2607, appHits=75, showAppHits=0, pcHits=293, showPcHits=2530, likes=2, shares=4, comments=4, approvalStatus=1, publishedTime=Sun Aug 29 22:36:14 CST 2021, publishedTimeString=2021-08-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 22:12:27 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:18:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=婴儿、儿童和青少年的医疗保健经验.pdf)])
婴儿、儿童和青少年的医疗保健经验.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190522, encodeId=d5db119052211, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39185247258, createdName=147d344cm33暂无昵称, createdTime=Sun Feb 06 15:38:15 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057985, encodeId=abd1105e9856c, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:17:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016588, encodeId=a55c101658805, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2e5503607, createdName=小嘚啵嘚, createdTime=Sat Sep 11 17:20:28 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013516, encodeId=6c04101351661, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7d4870154, createdName=ChiouXu, createdTime=Wed Sep 01 17:01:02 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2022-02-06 147d344cm33暂无昵称

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190522, encodeId=d5db119052211, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39185247258, createdName=147d344cm33暂无昵称, createdTime=Sun Feb 06 15:38:15 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057985, encodeId=abd1105e9856c, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:17:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016588, encodeId=a55c101658805, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2e5503607, createdName=小嘚啵嘚, createdTime=Sat Sep 11 17:20:28 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013516, encodeId=6c04101351661, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7d4870154, createdName=ChiouXu, createdTime=Wed Sep 01 17:01:02 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2021-10-06 henghengbobo

    收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190522, encodeId=d5db119052211, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39185247258, createdName=147d344cm33暂无昵称, createdTime=Sun Feb 06 15:38:15 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057985, encodeId=abd1105e9856c, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:17:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016588, encodeId=a55c101658805, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2e5503607, createdName=小嘚啵嘚, createdTime=Sat Sep 11 17:20:28 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013516, encodeId=6c04101351661, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7d4870154, createdName=ChiouXu, createdTime=Wed Sep 01 17:01:02 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2021-09-11 小嘚啵嘚

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190522, encodeId=d5db119052211, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39185247258, createdName=147d344cm33暂无昵称, createdTime=Sun Feb 06 15:38:15 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057985, encodeId=abd1105e9856c, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:17:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016588, encodeId=a55c101658805, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2e5503607, createdName=小嘚啵嘚, createdTime=Sat Sep 11 17:20:28 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013516, encodeId=6c04101351661, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7d4870154, createdName=ChiouXu, createdTime=Wed Sep 01 17:01:02 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2021-09-01 ChiouXu

    优秀

    0

拓展阅读

FDA 指导文件：为突破性设备计划指南选择更新：减少健康和医疗保健方面的差异

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2022-10-21

在临床医生中确定在门诊专科会诊中支持基于价值的医疗保健的活动的共识

荷兰鹿特丹伊拉斯谟大学 · 2023-01-20